Literature DB >> 7770505

Photophysical studies on human retinal lipofuscin.

E R Gaillard1, S J Atherton, G Eldred, J Dillon.   

Abstract

Fluorescent material generated in the human retina accumulates within lipofuscin granules of the retinal pigment epithelium (RPE) during aging. Its presence has been suggested to contributed to various diseases including age-related macular degeneration. Because this material absorbs light at wave lengths as long as 550 nm, photophysical studies were performed to determine whether lipofuscin could contribute to light damage and to determine if its composition is similar to a synthetically prepared lipofuscin. Time-resolved experiments were performed to monitor (1) fluorescence decay, (2) the UV-visible absorption of longer-lived excited states and (3) the formation and decay of singlet oxygen at 1270 nm. Steady-state and time-resolved fluorescence studies indicate that human and synthetic lipofuscin have fluorophores in common. Time-resolved absorption experiments on human retinal lipofuscin and synthetic lipofuscin showed the presence of at least two transient species, one absorbing at 430 nm (lifetime ca 7 microseconds) and a second absorbing at 580 nm, which decays via second order kinetics. In addition, there is a third absorbing species stable to several hundred milliseconds. The transient species at 430 nm is quenched by oxygen, suggesting that it is a triplet state. Subsequent studies showed the formation of singlet oxygen, which was monitored by its phosphorescence decay at 1270 nm. These studies demonstrate that lipofuscin can act as a sensitizer for the generation of reactive oxygen species that may contribute to the age-related decline of RPE function and blue light damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770505     DOI: 10.1111/j.1751-1097.1995.tb02343.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  37 in total

Review 1.  Ageing of the retinal pigment epithelium: implications for transplantation.

Authors:  Mike Boulton; Malgorzata Róanowska; Tim Wess
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-09       Impact factor: 3.117

Review 2.  Complement dysregulation in AMD: RPE-Bruch's membrane-choroid.

Authors:  Janet R Sparrow; Keiko Ueda; Jilin Zhou
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 3.  Retinal light toxicity.

Authors:  P N Youssef; N Sheibani; D M Albert
Journal:  Eye (Lond)       Date:  2010-10-29       Impact factor: 3.775

4.  Early biosignature of oxidative stress in the retinal pigment epithelium.

Authors:  Hilal Arnouk; Hyunju Lee; Ruonan Zhang; Hyewon Chung; Richard C Hunt; Wan Jin Jahng
Journal:  J Proteomics       Date:  2010-11-11       Impact factor: 4.044

5.  Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration.

Authors:  Keiko Ueda; Jin Zhao; Hye Jin Kim; Janet R Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

6.  Studies on the singlet oxygen scavenging mechanism of human macular pigment.

Authors:  Binxing Li; Faisal Ahmed; Paul S Bernstein
Journal:  Arch Biochem Biophys       Date:  2010-08-01       Impact factor: 4.013

Review 7.  Retinal photodamage mediated by all-trans-retinal.

Authors:  Tadao Maeda; Marcin Golczak; Akiko Maeda
Journal:  Photochem Photobiol       Date:  2012-04-24       Impact factor: 3.421

Review 8.  Bisretinoid Photodegradation Is Likely Not a Good Thing.

Authors:  Keiko Ueda; Hye Jin Kim; Jin Zhao; Janet R Sparrow
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 9.  Chemiexcitation and Its Implications for Disease.

Authors:  Douglas E Brash; Leticia C P Goncalves; Etelvino J H Bechara
Journal:  Trends Mol Med       Date:  2018-05-08       Impact factor: 11.951

10.  Light damage in Abca4 and Rpe65rd12 mice.

Authors:  Li Wu; Keiko Ueda; Taka Nagasaki; Janet R Sparrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-28       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.